Annual price review of medicines for 2025
Publication: pbbr
Author: Rita Roque de Pinho | Ana Guedes Machado
Date: 28 November 2024
The recent Administrative Ruling no. 293/2024/1, of November 15 established the regime for the annual price review of medicines purchased by services of the National Health System (SNS) and medicines delivered within the scope of the OTC market, including generic and biosimilar medicines, for the year 2025.